Adjuncts to preparing wounds for closure Hyperbaric oxygen, growth factors, skin substitutes, negative pressure wound therapy (vacuum-assisted closure)

Foot and Ankle Clinics

Volumn 6, Issue 4, 2001, Pages 661-682

  Hopf, Harriet W ^a   Humphrey, Lisa M ^a   Puzziferri, Nancy ^a   West, Judith M ^a   Attinger, Christopher E ^b   Hunt, Thomas K ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH PROMOTOR;

ARTIFICIAL SKIN; CHRONIC DISEASE; FOOT INJURY; HUMAN; HYPERBARIC OXYGEN; MULTIMODALITY CANCER THERAPY; REVIEW; SUCTION; WOUND HEALING;

CHRONIC DISEASE; COMBINED MODALITY THERAPY; FOOT INJURIES; GROWTH SUBSTANCES; HUMANS; HYPERBARIC OXYGENATION; SKIN, ARTIFICIAL; SUCTION; WOUND HEALING;

EID: 0035554230     PISSN: 10837515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-7515(02)00008-6     Document Type: Review

References (78)

1. Akça O, Melischek M, Scheck T, Hellwagner K, Arkilic C, Kurz A, et al. Postoperative pain and subcutaneous oxygen tension, [letter] Lancet 1999;354:41-2.
2. Allen D, Maguire J, Mahdavian M, Wicke C, Marcocci L, Scheuenstuhl H, et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg 1997;132:991-6.
3. Argenta LC, Morykwas MJ. Vacuum-assisted closure: a new method for wound control and treatment: clinical experience [Comment in: Ann Plast Surg 2000;45:332-4; discussion 335-6 UI: 20441845]. Ann Plast Surg 1997;38:563-76; discussion, 577.
4. Atnip RG, Burke JF. Skin coverage. Curr Probl Surg 1983;20:623-83.
5. Babior BM. Oxygen-dependent microbial killing by phagocytes. N Engl J Med 1978;198: 659-68.
6. Baumgartner I, Pieczek A, Manor O, Blair R, Kearny M, Walsh K, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998;97:1114-23.
7. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993;165:728-37.
8. Bennett NT, Schultz GS. Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am J Surg 1993;166:74-81.
9. Bondoc CC, Burke JF. Clinical experience with viable frozen human skin and a frozen skin bank. Ann Surg 1971;174:371-82.
10. Bowersox J, Stauss M, Hart G. Clinical experience with hyperbaric oxygen therapy in the salvage of ischemic skin flaps and grafts. J Hyperb Med 1986;1:141-9.
11. Brain A, Purkis P, Coates P, et al. Survival of cultured allogeneic keratinocytes transplanted to deep dermal bed assessed with probe specific for Y chromosome. BMJ (Clinical Research Ed.) 1989;298:917-19.
12. Bromberg B, Song I. Pigskin heterografts. Minn Med 1965;48:1605-9.
13. DeJong L, Kemp A. Stoicheiometry and kinetics of the prolyl 4-hydroxylase partial reaction. Biochim Biophys Acta 1984;787:105-11.
14. Demling R, De Santi L. Closure of the "non-healing wound" corresponds with correction of weight loss using the anabolic agent oxandrolone. Ostomy/Wound Management 1998;44:58-62.
15. Demling RH. Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair Regen 2000;8:97-102.
16. Demling RH, Orgill DP. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care 2000;15:12-7.
17. Dvonch VM, Murphey RJ, Matsuoka J, Grotendorst GR. Changes in growth factor levels in human wound fluid. Surgery 1992;112:18-23.
18. Ersek RA, Lorio J. The most indolent ulcers of the skin treated with porcine xenografts and silver ions. Surgery. Gynecology and Obstetrics 1984;158:431-6.
19. Faglia E, Favales F, Aldeghi A, Calia P, Quarantiello A, Oriani G, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 1996;19:1338-43.
20. Falanga V, Margolis D, Alvarez O, Auletta M, Maggiacomo F, Altman M, et al. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group [comments]. Arch Dermatol 1998;134: 293-300.
21. Feldmeier J, Heimbach R, Davolt D, Court WS, Stegmann BJ, Sheffield PJ. Hyperbaric oxygen as an adjunctive treatment for delayed radiation injuries of the abdomen and pelvis. Undersea Hyperb Med 1996;23: 205-13.
22. Gentzkow GD, Iwasaki SD, Hershon KS, Mengel M, Prendergast JJ, Ricotta JJ, et al. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers [comments]. Diabetes Care 1996;19:350-4.
23. Gibson J, Angeles A, Hunt T. Increased oxygen tension potentiates angiogenesis. Surg Forum 1997;87:696-9.
24. Gosain A, Rabkin J, Reymond J-P, Jensen JA, Hunt TK, Upton RA. Tissue oxygen tension and other indicators of blood loss or organ perfusion during graded hemorrhage. Surgery 1991; 109:523-32.
25. Gottrup F, Firmin R, Rabkin J, Halliday BJ, Hunt TK. Directly measured tissue oxygen tension and arterial oxygen tension assess tissue perfusion. Crit Care Med 1987;15:1030-6.
26. Greenhalgh DG. The role of growth factors in wound healing. J Trauma 1996;41:159-67.
27. Greif R, Akça O, Horn EP, Kurz A, Sesster DI and Outcomes Research Group. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection. Outcomes Research Group [comments]. N Engl J Med 2000;342:161-7.
28. Haydock D, Hill G. Impaired wound healing in surgical patients with varying degrees of malnutrition. JPEN 1986;10:550-4.
29. Haydock D, Hill G. Improved wound healing response in surgical patients receiving intravenous nutrition. Br J Surg 1987;74:320-3.
30. Herndon DN, Nguyen TT, Gilpin DA. Growth factors: local and systemic. Arch Surg 1993; 128:1227-33.
31. Hopf H, McKay W, West J, Hunt TK. Percutaneous lumbar sympathetic block increases tissue oxygen in patients with local tissue hypoxia in non-healing wounds. Anesth Analg 1997.
32. Hopf HW, Hunt TK, West JM, Blomquist P, Goodson WH, Jensen JA, et al. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. Arch Surg 1997; 132:997-1004; discussion, 1005.
33. Hunt T, Hopf H. Nutrition in wound healing. In: Fischer J, editor. Nutrition and metabolism in the surgical patient. 2nd edition. Boston: Little, Brown and Company; 1996. p. 423-41.
34. Hunt TK, Hopf HW. Wound healing and wound infection. What surgeons and anesthesiologists can do. Surg Clin North Am 1997;77:587-606.
35. Hutton JJ, Tappel AL, Udenfriend S. Cofactor and substrate requirements of collagen proline hydroxylase. Arch Biochem Biophys 1967;118:231-40.
36. Ignacio DR, Pavot AP, Azer RN, Wisotsky L. Topical oxygen therapy treatment of extensive leg and foot ulcers. J Am Podiatr Med Assoc 1985;75:196-9.
37. Jensen JA, Goodson WH, Hopf HW, Hunt TK. Cigarette smoking decreases tissue oxygen. Arch Surg 1991;126:1131-4.
38. Jensen JA, Goodson WH, Omachi RS, Lindenfeld SM, Hunt TK. Subcutaneous tissue oxygen tension falls during hemodialysis. Surgery 1987;101:416-21.
39. Jensen JA, Hunt TK, Scheuenstuhl H, Banda M. Effect of lactate, pyruvate and pH on secretion of angiogenesis and mitogenesis factors by macrophages. Lab Invest 1986;54:574-8.
40. Jonsson K, Jensen JA, Goodson WHI, Hunt TK. Wound healing in subcutaneous tissue in surgical patients in relation to oxygen availability. Surg Forum 1986;37:86-8.
41. Kantor J, Margolis DJ. A multicentre study of percentage change in venous leg ulcer area as a prognostic index of healing at 24 weeks. Br J Dermatol 2000;142:960-4.
42. Kaufman T, Alexander JW, MacMillan BG. Topical oxygen and burn wound healing: a review. Burns Incl Therm Inj 1983;9:169-73.
43. Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z, Banda MJ. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 1983;221:1283-5.
44. Krummel TM, Michna BA, Thomas BL, Spora MZ, Nelson JM, Sulzberg AM, et al. Transforming growth factor-beta induces fibrosis in a fetal wound model. J Pediatr Surg 1988; 23:647-52.
45. Kurz A, Sessler D, Lenhardt R, Hopf HW, Hunt TK, Polak G, et al. Perioperative Normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996;334:1209-15.
46. Lee K, Stotts N. Support of the growth hormone-somatomedin system to facilitate healing. Heart Lung 1990;19:157-62.
47. Marx R, Johnson R, Kline S. Prevention of osteo-radionecrosis: a randomized prospective clinical trial of hyperbaric oxygen versus penicillin. J Am Dent Assoc 1985;111:49-54.
48. Mauras N, Haymond MW Metabolic effects of recombinant human insulin-like growth factor-I in humans: comparison with recombinant human growth hormone. Pediatr Nephrol 1996;10: 318-23.
49. Medawar PS. The behavior of mammalian skin epithelium under strictly anaerobic conditions. Q J Microsc Sci 1947;88:27.
50. Mellin TN, Cashen DE, Ronan JJ, Murphy BS, DiSolvo J, Thomas KA. Acidic fibroblast growth factor accelerates dermal wound healing in diabetic mice. J Invest Dermatol 1995;104:850-5.
51. Meyer-Ingold W. Wound therapy: growth factors as agents to promote healing. Tibtech 1993; 11:387-92.
52. Morykwas MJ, Argenta LC. Nonsurgical modalities to enhance healing and care of soft tissue wounds. J South Orthop Assoc 1997;6:279-88.
53. Myers R. Hyperbaric oxygen therapy for trauma: crush injury, compartment syndrome, and other acute traumatic peripheral ischemias. Int Anesthesiol Clin 2000;38:139-51.
54. Myllyla R, Tuderman L, Kivirikko KI. Mechanism of the prolyl hydroxylase reaction. 2. Kinetic analysis of the reaction sequence. Eur J Biochem 1977;80:349-57.
55. Niinikoski J, Heughan C, Hunt TK. Oxygen tensions in human wounds. J Surg Res 1972;12: 77-82.
56. Niinikoski J, Jussila P, Vihersaari T. Radical mastectomy wound as a model for studies of human wound metabolism. Am J Surg 1973;126:53-8.
57. Puzziferri N, West J, Hunt T, Hopf HW, et al. Local warming increases oxygenation and decreases pain in ischemic ulcers. Wound Repair Regen 2001;9:146.
58. Rees RS, Robson MC, Smiell JM, Perry BH, et al. Becaplermin gel in the treatment of presure ulcers: a phase II randomized double-blinded, placebo-controlled study. Wound Repair Regen 1999;7:141-7.
59. Robson MC, Mucstoe TA, Hunt TK. The future of recombinant growth factors in wound healing. Am J Surg 1998;176:80S-2S.
60. Rollins M, Gimbel M, Gibson J, Hunt TK, Hopf HW. Accuracy of a polarographic electrode at high oxygen concentrations. Adv Exp Med Biol 2002.
61. Rudkin GH, Miller TA. Growth factors in surgery. Plast Reconstr Surg 1996;97:469-75.
62. Saito H. Anabolic agents in trauma and sepsis: repleting body mass and function. Nutrition 1998;14:554-6.
63. Sheffield C, Sessler D, Hopf H, Schroeder M, Moayeri A, Hunt TK. Centrally and locally mediated thermoregulatory responses alter subcutaneous oxygen tension. Wound Repair Regen 1996;4:339-45.
64. Sheffield PJ. Tissue oxygen measurements. In: Davis JC, Hunt TK, editors. Problem wounds: the role of oxygen. New York: Elsevier; 1988. p. 17-51.
65. Sheikh A, Gibson J, Rollins M, Hopf HW, Hussain Z, Hunt TK. Effect of hyperoxia on VEGF levels in a wound model. Arch Surg 2000;135:1293-7.
66. Smith B, Desvigne L, Slade J, Dooley JW, Warren DC, et al. Transcutaneous oxygen measurements predict healing of leg wounds with hyperbaric therapy. Wound Repair Regen 1996;4: 224-9.
67. Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. J Vasc Surg 1995;21:71-81.
68. Steed DL. The role of growth factors in wound healing. Surg Clin North Am 1997;77:575-85.
69. Steenfos HH. Growth factors and wound healing. Scandinavian Journal of Plastic Reconstructive and Hand Surgery 1994;28:95-105.
70. Tavis MJ, Thornton J, Danet R, Bartlett RH. Current status of skin substitutes. Surg Clin North Am 1978;58:1233-48.
71. Tsurmi Y, Kearney M, Chen D, Silver M, Takeshita S, Yang J, et al. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 1997;96:382-8.
72. Valavaara M, Heikkinen E, Kulonen E. Effect of hypophysectomy on the incorporation of proline in the collagen fractions. Experimentia 1968;24:779-80.
73. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. The Apligraf Diabetic Foot Ulcer Study. Diabetes Care 2001;24:290-5.
74. Wainwright D, Madden M. Luterman L, Hunt J, Monafo W, Heimbuch D, et al. Clinical evaluation of an acellular allograft dermal matrix in full thickness burns. J Burn Care Rehab 1996;17:124-36.
75. Wütschert R, Bounameaux H. Determination of amputation level in ischemic limbs. Reappraisal of the measurement of TcPo2. Diabetes Care 1997;20:1315-8.
76. Yue-Liang D, Shu-Sung P, De-Zhen W, et al. Clinical and histological observations on the application of intermingled auto- and porcine-skin heterograft in third degree burns. Burns 1981;9:381.
77. Zabel DD, Feng JJ, Scheuenstuhl H, et al. Lactate stimulation of macrophage-derived angiogenic activity is associated with inhibition of poly(ADP-ribos) synthesis. Lab Invest 1996;74:644-9.
78. Zhao LL, Davidson JD, Wee SC, et al. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg 1994;129:1043-9.